The 2021-2026 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) - Image 1

Out of Stock

This item is currently unavailable

The 2021-2026 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)

Subjects

Out of Stock

Price data last checked 158 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 158 days. Could come back at any time — we're watching for you.

Out of stock 158 days · last price £795 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 573 days • 573 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 573 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (573 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 573 days

Product Specifications

Format: paperback
ASIN: B082JP3WQP
Category: Books > Subjects
Domain: Amazon UK
Release Date: 13 February 2020
Listed Since: 13 December 2019

The 2021-2026 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)

Gone for 158 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Product Specifications

Similar Products You Might Like

The 2021-2026 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)

Esophageal Cancer: Prevention, Diagnosis and Therapy

The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products

Esophageal Cancer: Prevention, Diagnosis and Therapy

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China

Esophageal Cancer, An Issue of Thoracic Surgery Clinics (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)

The 2025-2030 World Outlook for Esophagus-Targeting Smart Pills

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean

Esophageal Cancer: Diagnosis and Treatment

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States

Esophageal Cancer and Beyond

The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies

Risk Factors and Therapy of Esophagus Cancer

Risk Factors and Therapy of Esophagus Cancer

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States

The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

Esophageal Diseases: Diagnosis and Treatment

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Africa

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India

The 2025-2030 World Outlook for Cancer Specialty Hospitals

The 2023-2028 World Outlook for Embolization in Interventional Oncology

Esophageal Squamous Cell Carcinoma: Diagnosis and Treatment